Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 11/20 | 0.50 |
| ▸ | LPAR2 | Q9HBW0 | 10/20 | 0.50 |
| ▸ | LPAR1 | Q92633 | 5/20 | 0.50 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.41 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.41 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.41 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.41 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28541811 | 0.88 | LPAR3 (0.36) | LPAR3LPAR2LPAR1CSNK2A2CSNK2B | |
| SCHEMBL10412259 | 0.87 | LPAR3 (0.43) | LPAR3LPAR2LPAR1CSNK2A2CSNK2B | |
| SCHEMBL2804214 | 0.86 | SAT1 (0.44) | LPAR3LPAR2LPAR1CSNK2A2CSNK2B | |
| SCHEMBL21829159 | 0.83 | CYP3A4 (0.50) | LPAR3LPAR2LPAR1LMNACYP3A4 | |
| SCHEMBL2804213 | 0.81 | LMNA (0.33) | LMNACYP3A4 | |
| SCHEMBL16865455 | 0.81 | LMNA (0.33) | LMNACYP3A4 | |
| SCHEMBL13789648 | 0.81 | LPAR3 (0.55) | LPAR3LPAR2LPAR1ENPP2 | |
| SCHEMBL14090771 | 0.79 | LPAR1 (0.41) | LPAR3LPAR2LPAR1ENPP2 | |
| SCHEMBL16681909 | 0.78 | LPAR3 (0.54) | LPAR3LPAR2LPAR1CSNK2A2CSNK2B | |
| SCHEMBL10881831 | 0.78 | LMNA (0.32) | LMNACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113372630-B | Conjugated diene polymer composition and tire | 旭化成株式会社 | 2023-05-26 | — | — | CN | claimed |
| WO-2026087601-A1 | ELASTOMERIC COMPOUNDS AND RELATED SUMMER TYRES FOR VEHICLE WHEELS | PIRELLI TYRE S.P.A. (IT) | 2026-04-30 | — | — | WO | disclosed |
| EP-3260471-B1 | MODIFIED CONJUGATED DIENE POLYMER AND METHOD FOR PRODUCING SAME, RUBBER COMPOSITION, AND TIRE | ASAHI CHEMICAL IND (JP) | 2026-04-08 | — | — | EP | disclosed |
| EP-4702090-A1 | TYRE FOR VEHICLE WHEEL WITH SUPERIOR WEAR RESISTANCE AND GRIP | Pirelli Tyre S.p.A. (IT) | 2026-03-04 | — | — | EP | disclosed |
| EP-4703396-A1 | CONJUGATED DIENE POLYMER AND METHOD FOR PRODUCING CONJUGATED DIENE POLYMER | Asahi Kasei Kabushiki Kaisha (JP) | 2026-03-04 | — | — | EP | disclosed |
| EP-4702089-A1 | TYRE FOR VEHICLE WHEEL WITH SUPERIOR WEAR RESISTANCE AND GRIP | Pirelli Tyre S.p.A. (IT) | 2026-03-04 | — | — | EP | disclosed |
| EP-4703397-A1 | CONJUGATED DIENE POLYMER AND METHOD FOR PRODUCING CONJUGATED DIENE POLYMER | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2026-03-04 | — | — | EP | disclosed |
| US-20260055216-A1 | Conjugated Diene-Based Polymer, Formed Body, Production Method for Conjugated Diene-Based Polymer, Rubber Composition, and Tire | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2026-02-26 | — | — | US | disclosed |
| EP-3502145-B1 | MODIFIED CONJUGATED DIENE-BASED POLYMER, RUBBER COMPOSITION AND TIRE | ASAHI CHEMICAL IND (JP) | 2025-09-17 | — | — | EP | disclosed |
| EP-4570827-A1 | CONJUGATED DIENE-BASED POLYMER, MOLDED BODY, PRODUCTION METHOD FOR CONJUGATED DIENE-BASED POLYMER, RUBBER COMPOSITION, AND TIRE | Asahi Kasei Kabushiki Kaisha (JP) | 2025-06-18 | — | — | EP | disclosed |
| US-10434821-B2 | Modified conjugated diene-based polymer and production method therefor, rubber composition and tire | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2019-10-08 | — | — | US | disclosed |
| EP-3309180-B1 | MODIFIED CONJUGATED DIENE-BASED POLYMER AND PRODUCTION METHOD | ASAHI CHEMICAL IND (JP) | 2019-08-07 | — | — | EP | disclosed |
| EP-3502145-A1 | MODIFIED CONJUGATED DIENE POLYMER, RUBBER COMPOSITION, AND TIRE | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2019-06-26 | — | — | EP | disclosed |
| US-20180342767-A1 | GEL POLYMER ELECTROLYTE AND LITHIUM SECONDARY BATTERY INCLUDING THE SAME | LG CHEM, LTD. (KR) | 2018-11-29 | — | — | US | disclosed |
| US-20180162167-A1 | Modified Conjugated Diene-Based Polymer and Production Method Therefor, Rubber Composition and Tire | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2018-06-14 | — | — | US | disclosed |
| EP-3309180-A1 | MODIFIED CONJUGATED DIENE POLYMER, METHOD FOR PRODUCING SAME, RUBBER COMPOSITION AND TIRE | Asahi Kasei Kabushiki Kaisha (JP) | 2018-04-18 | — | — | EP | disclosed |
| US-20180066076-A1 | Modified Conjugated Diene-Based Polymer and Production Method Therefor, Rubber Composition and Tire | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2018-03-08 | — | — | US | disclosed |
| EP-3260471-A1 | MODIFIED CONJUGATED DIENE POLYMER AND METHOD FOR PRODUCING SAME, RUBBER COMPOSITION, AND TIRE | Asahi Kasei Kabushiki Kaisha (JP) | 2017-12-27 | — | — | EP | disclosed |
| US-9329479-B2 | Lithographic printing plate precusor | AGFA GRAPHICS NV (BE) | 2016-05-03 | — | — | US | disclosed |
| US-20150168837-A1 | LITHOGRAPHIC PRINTING PLATE PRECUSOR | ECO3 BV (BE) | 2015-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260055216-A1 | Conjugated Diene-Based Polymer, Formed Body, Production Method for Conjugated Diene-Based Polymer, Rubber Composition, and Tire | HMGB2, HMGB1, HMGB3 | LPAR3 1250/4885LPAR2 1837/4885LPAR1 755/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.